At 96 h post-infection, the percentage of TNF-α-positive macrophages (12.7%) in PRV-infected mice with NSA treatment was markedly lower than that in PRV-infected mice without NSA treatment (32.8%) (Fig. 7A). The gene discussed is TNF; the disease is infection.